Dr. Roger Packer, Senior Director of the Center for Neuroscience and Behavioral Medicine at Children’s National Hospital (USA), joined the The Lead in Peds podcast on September 24 to discuss recent advances in therapies for pediatric brain tumors.
In the episode “Breaking Barriers: Emerging Therapies in Pediatric Brain Tumors,” Dr. Packer addressed the challenges of bringing new discoveries to patients and emphasized the importance of more agile and collaborative research models.
He also mentioned the MBI as an example of an effort that is helping shorten this path. Packer recalled its origin: a question posed by Fernando Goldsztein,
“If I could help change the course of science, how would you do it?”
From that conversation, in 2021, the MBI and the Cure Group 4 Consortium were born, bringing together experts from around the world to accelerate the development of therapies for medulloblastoma.
In just two years, two new therapies were already underway, a remarkable achievement in a field where time is everything.
Listen to the full The Lead in Peds episode here.
